NCT01899573View on ClinicalTrials.gov

Percutaneous Left Ventricular Reshaping to Reduce Functional Mitral Regurgitation and Improve LV Function

NACompletedINTERVENTIONAL

Enrollment

8

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

March 31, 2016

Conditions

Functional Mitral Regurgitation

Interventions

DEVICE

AccuCinch® Ventriculoplasty System

Percutaneous intervention for the treatment of functional mitral regurgitation

Trial Locations (1)

Unknown

Clinica CardioVID, Medellín

Sponsors

Lead Sponsor

Ancora Heart, Inc.

All Listed Sponsors

lead

Ancora Heart, Inc.

INDUSTRY

NCT01899573 - Percutaneous Left Ventricular Reshaping to Reduce Functional Mitral Regurgitation and Improve LV Function | Biotech Hunter | Biotech Hunter